Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. CME Group (CME) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question. CME Group is one of 858 individual stocks in the Finance sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CME Group is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate for CME's full-year earnings has moved 6.9% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving. Based on the latest available data, CME has gained about 19% so far this year. Meanwhile, stocks in the Finance group have gained about 6.3% on average. This means that CME Group is outperforming the sector as a whole this year. Another Finance stock, which has outperformed the sector so far this year, is ACNB (ACNB). The stock has returned 10.5% year-to-date. Over the past three months, ACNB's consensus EPS estimate for the current year has increased 15.7%. The stock currently has a Zacks Rank #2 (Buy). Breaking things down more, CME Group is a member of the Securities and Exchanges industry, which includes 7 individual companies and currently sits at #12 in the Zacks Industry Rank. Stocks in this group have gained about 16.1% so far this year, so CME is performing better this group in terms of year-to-date returns. In contrast, ACNB falls under the Banks - Southwest industry. Currently, this industry has 19 stocks and is ranked #20. Since the beginning of the year, the industry has moved -0.3%. CME Group and ACNB could continue their solid performance, so investors interested in Finance stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues CME Group Inc. (CME):Free Stock Analysis Report ACNB Corporation (ACNB):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Is CME Group (CME) Stock Outpacing Its Finance Peers This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...